Investor Centre Corporate Directory and Governance

Email	registrar@securitytransfer.com.au
Phone	+61 (0) 8 9315 2333
	Monday to Friday between 8:00am and 5:00pm WST
Fax	+61 (0) 8 9315 2233
Postal Address	PO Box 535, Applecross, WA 6953, Australia
Street Address	770 Canning Highway, Applecross WA, 6153 Australia

Company Auditor

Grant Thornton Audit Pty Ltd

Email	communications@au.gt.com
Phone	+61 (0)3 8320 2222
Fax	+61 (0)3 8320 2222
Street Address	Collins Square, Tower 5 727 Collins Street Melbourne VIC 3008 Australia

Secure Shopping

Fully protected by Incapsula

Get Connected

Join our social networks

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of specifically targeted polyclonal antibodies.

The company presently has three drug candidates in clinical development and several in early stage preclinical development. Immuron believes its therapeutic drug candidates have the potential to transform the existing treatment paradigms for moderate to severe Campylobacteriosis, recurrent Clostridiodes difficile (C.difficle) infections, Enterotoxigenic Escherichia coli (ETEC) infections, Shigellosis (Bacillary dysentery) and travelers’ diarrhea.

Payment Options

Contact Information

Address: Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131 Australia
Phone: +613 8892 4854
Fax: +613 9899 8533

Categories

Information

Corporate Directory and Governance

Share Registry